Xeris Biopharma Holdings Inc
NASDAQ:XERS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Xeris Biopharma Holdings Inc
NASDAQ:XERS
|
US |
|
S
|
Syncom Formulations (India) Ltd
BSE:524470
|
IN |
|
B
|
British American Tobacco PLC
XBER:BMT
|
UK |
|
C
|
C3.ai Inc
F:724
|
US |
|
Infosys Ltd
F:IOY
|
IN |
|
L
|
Legible Inc
CNSX:READ
|
CA |
|
Subsea 7 SA
OSE:SUBC
|
UK |
|
F
|
First Horizon Corp
F:FT2
|
US |
Intrinsic Value
The intrinsic value for Xeris Biopharma Holdings Inc (XERS) under the Base Case is hidden
USD.
Compared with the current market price of 6.16 USD, the stock appears hidden
.
XERS looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if XERS is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Xeris Biopharma Holdings Inc.
The intrinsic value for Xeris Biopharma Holdings Inc (XERS) under the Base Case is hidden USD.
Compared with the current market price of 6.16 USD, the stock appears hidden.
